Cardiac toxicity of chemotherapy for breast cancer: do angiotensin-converting enzyme inhibitors and beta blockers protect?

Cardiotoxicity is a relatively frequent and potentially serious side effect of anticancer treatments, particularly anthracyclines and trastuzumab, widely used in the treatment of breast cancer. The increase in cancer survivors has generated a growing interest in the prevention of cardiotoxicity. Alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisceglia, Irma, Mistrulli, Raffaella, Cartoni, Domenico, Matera, Sabrina, Petrolati, Sandro, Canale, Maria Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
CCC 2023 - State of the Art Cardiology Supplement Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120962/
https://www.ncbi.nlm.nih.gov/pubmed/37091667
http://dx.doi.org/10.1093/eurheartjsupp/suad062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120962/
https://www.ncbi.nlm.nih.gov/pubmed/37091667
http://dx.doi.org/10.1093/eurheartjsupp/suad062

Ejemplares similares